Evidence map›Paper›PMID 34105235›Full record

ArticleEMBO reports2021

Aneuploid senescent cells activate NF-κB to promote their immune clearance by NK cells.

Ruoxi W Wang, Sonia Viganò, Uri Ben-David, Angelika Amon, Stefano Santaguida

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 79 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Non-cell-autonomous mechanisms of tumor initiation and relapse by chromosomal instability.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. The Hallmarks of Aneuploidy in Cancer and Congenital Syndromes.Annual review of genomics and human genetics · 2025
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Targeting chromosomal instability in patients with cancer.Nature reviews. Clinical oncology · 2024
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Ruoxi W WangDepartment of Biology, Massachusetts Institute of Technology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
Sonia ViganòDepartment of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0003-0437-0087
Uri Ben-DavidDepartment of Human Molecular Genetics & Biochemistry, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.ORCID 0000-0001-7098-2378
Angelika AmonDepartment of Biology, Massachusetts Institute of Technology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
Stefano SantaguidaDepartment of Experimental Oncology at IEO, European Institute of Oncology IRCCS, Milan, Italy.ORCID 0000-0002-1501-6190
Howard Hughes Medical Institute · USEuropean Institute of Oncology · ITTel Aviv University · ILUniversity of Milan · IT

Funding

Regulation of mitosis by proteolysis in yeastR01CA206157 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI AMON, ANGELIKA B · 2016 to 2020
$1.4M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA206157
6 · The paper itself

Abstract

The immune system plays a major role in the protection against cancer. Identifying and characterizing the pathways mediating this immune surveillance are thus critical for understanding how cancer cells are recognized and eliminated. Aneuploidy is a hallmark of cancer, and we previously found that untransformed cells that had undergone senescence due to highly abnormal karyotypes are eliminated by natural killer (NK) cells in vitro. However, the mechanisms underlying this process remained elusive. Here, using an in vitro NK cell killing system, we show that non-cell-autonomous mechanisms in aneuploid cells predominantly mediate their clearance by NK cells. Our data indicate that in untransformed aneuploid cells, NF-κB signaling upregulation is central to elicit this immune response. Inactivating NF-κB abolishes NK cell-mediated clearance of untransformed aneuploid cells. In cancer cell lines, NF-κB upregulation also correlates with the degree of aneuploidy. However, such upregulation in cancer cells is not sufficient to trigger NK cell-mediated clearance, suggesting that additional mechanisms might be at play during cancer evolution to counteract NF-κB-mediated immunogenicity.

Indexed as

Killer Cells, NaturalNF-kappa BAneuploidyCellular SenescenceHumansSignal TransductionNF-kappa Baneuploidycomplex karyotypesimmune clearanceNF-κBsenescence

Identifiers

PMID34105235
PMCPMC8339690
OpenAlexW3167286448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.